These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 17440491)

  • 1. Soluble epoxide hydrolase: a novel therapeutic target in stroke.
    Zhang W; Koerner IP; Noppens R; Grafe M; Tsai HJ; Morisseau C; Luria A; Hammock BD; Falck JR; Alkayed NJ
    J Cereb Blood Flow Metab; 2007 Dec; 27(12):1931-40. PubMed ID: 17440491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble epoxide hydrolase inhibition and gene deletion are protective against myocardial ischemia-reperfusion injury in vivo.
    Motoki A; Merkel MJ; Packwood WH; Cao Z; Liu L; Iliff J; Alkayed NJ; Van Winkle DM
    Am J Physiol Heart Circ Physiol; 2008 Nov; 295(5):H2128-34. PubMed ID: 18835921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble epoxide hydrolase gene deletion is protective against experimental cerebral ischemia.
    Zhang W; Otsuka T; Sugo N; Ardeshiri A; Alhadid YK; Iliff JJ; DeBarber AE; Koop DR; Alkayed NJ
    Stroke; 2008 Jul; 39(7):2073-8. PubMed ID: 18369166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An epoxide hydrolase inhibitor, 12-(3-adamantan-1-yl-ureido)dodecanoic acid (AUDA), reduces ischemic cerebral infarct size in stroke-prone spontaneously hypertensive rats.
    Dorrance AM; Rupp N; Pollock DM; Newman JW; Hammock BD; Imig JD
    J Cardiovasc Pharmacol; 2005 Dec; 46(6):842-8. PubMed ID: 16306811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble Epoxide Hydrolase Inhibitor Ameliorates Olfactory Dysfunction, Modulates Microglia Polarization, and Attenuates Neuroinflammation after Ischemic Brain Injury.
    Yeh CF; Chuang TY; Lan MY; Lin YY; Huang WH; Hung YW
    J Neuroimmune Pharmacol; 2024 Oct; 19(1):54. PubMed ID: 39417923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble epoxide hydrolase inhibitor enhances synaptic neurotransmission and plasticity in mouse prefrontal cortex.
    Wu HF; Yen HJ; Huang CC; Lee YC; Wu SZ; Lee TS; Lin HC
    J Biomed Sci; 2015 Oct; 22():94. PubMed ID: 26494028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of soluble epoxide hydrolase attenuates post-ischemic neuronal hyperexcitation and confers resilience against stroke with TrkB activation.
    Chang LH; Lin HC; Huang SS; Chen IC; Chu KW; Chih CL; Liang YW; Lee YC; Chen YY; Lee YH; Lee IH
    Sci Rep; 2018 Jan; 8(1):118. PubMed ID: 29311641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substituted adamantyl-urea inhibitors of the soluble epoxide hydrolase dilate mesenteric resistance vessels.
    Olearczyk JJ; Field MB; Kim IH; Morisseau C; Hammock BD; Imig JD
    J Pharmacol Exp Ther; 2006 Sep; 318(3):1307-14. PubMed ID: 16772540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble epoxide hydrolase: a new target for cardioprotection.
    Gross GJ; Nithipatikom K
    Curr Opin Investig Drugs; 2009 Mar; 10(3):253-8. PubMed ID: 19333883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of soluble epoxide hydrolase does not protect against endotoxin-mediated hepatic inflammation.
    Fife KL; Liu Y; Schmelzer KR; Tsai HJ; Kim IH; Morisseau C; Hammock BD; Kroetz DL
    J Pharmacol Exp Ther; 2008 Dec; 327(3):707-15. PubMed ID: 18815352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble epoxide hydrolase inhibitor trans-4-[4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid is neuroprotective in rat model of ischemic stroke.
    Shaik JS; Ahmad M; Li W; Rose ME; Foley LM; Hitchens TK; Graham SH; Hwang SH; Hammock BD; Poloyac SM
    Am J Physiol Heart Circ Physiol; 2013 Dec; 305(11):H1605-13. PubMed ID: 24043255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble epoxide inhibition is protective against cerebral ischemia via vascular and neural protection.
    Simpkins AN; Rudic RD; Schreihofer DA; Roy S; Manhiani M; Tsai HJ; Hammock BD; Imig JD
    Am J Pathol; 2009 Jun; 174(6):2086-95. PubMed ID: 19435785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic deletion or pharmacological inhibition of soluble epoxide hydrolase reduces brain damage and attenuates neuroinflammation after intracerebral hemorrhage.
    Wu CH; Shyue SK; Hung TH; Wen S; Lin CC; Chang CF; Chen SF
    J Neuroinflammation; 2017 Nov; 14(1):230. PubMed ID: 29178914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epoxyeicosanoid Signaling Provides Multi-target Protective Effects on Neurovascular Unit in Rats After Focal Ischemia.
    Liu Y; Wan Y; Fang Y; Yao E; Xu S; Ning Q; Zhang G; Wang W; Huang X; Xie M
    J Mol Neurosci; 2016 Feb; 58(2):254-65. PubMed ID: 26545915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble epoxide hydrolase inhibitor, AUDA, prevents early salt-sensitive hypertension.
    Li J; Carroll MA; Chander PN; Falck JR; Sangras B; Stier CT
    Front Biosci; 2008 May; 13():3480-7. PubMed ID: 18508449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble epoxide hydrolase activity determines the severity of ischemia-reperfusion injury in kidney.
    Lee JP; Yang SH; Lee HY; Kim B; Cho JY; Paik JH; Oh YJ; Kim DK; Lim CS; Kim YS
    PLoS One; 2012; 7(5):e37075. PubMed ID: 22590647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic effects of the soluble epoxide hydrolase (sEH) inhibitor AUDA on atherosclerotic diseases.
    Zhang J; Liu YS; Lu QH
    Pharmazie; 2015 Jan; 70(1):24-8. PubMed ID: 25975094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of protection by soluble epoxide hydrolase inhibition in type 2 diabetic stroke.
    Zuloaga KL; Krasnow SM; Zhu X; Zhang W; Jouihan SA; Shangraw RE; Alkayed NJ; Marks DL
    PLoS One; 2014; 9(5):e97529. PubMed ID: 24824753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of soluble epoxide hydrolase in exacerbation of stroke by streptozotocin-induced type 1 diabetes mellitus.
    Jouihan SA; Zuloaga KL; Zhang W; Shangraw RE; Krasnow SM; Marks DL; Alkayed NJ
    J Cereb Blood Flow Metab; 2013 Oct; 33(10):1650-6. PubMed ID: 23899929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble epoxide hydrolase is a main effector of angiotensin II-induced hypertension.
    Jung O; Brandes RP; Kim IH; Schweda F; Schmidt R; Hammock BD; Busse R; Fleming I
    Hypertension; 2005 Apr; 45(4):759-65. PubMed ID: 15699457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.